tulathromycin

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2004-2018
0102020042018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The pharmacokinetic (PK) profile of tulathromycin, administered to calves subcutaneously at the dosage of 2.5 mg/kg, was… (More)
Is this relevant?
2011
2011
Tulathromycin is a triamilide antibiotic that maintains therapeutic concentrations for an extended period of time. The drug is… (More)
Is this relevant?
2010
2010
This study determined the antimicrobial activity of tulathromycin against Rhodococcus equi in vitro. Ninety-eight virulent… (More)
Is this relevant?
2006
2006
The efficacy of a single dose of tulathromycin, a novel triamilide antimicrobial of the macrolide class, given at 2.5 mg/kg or 5… (More)
Is this relevant?
2005
2005
The clinical efficacy of tulathromycin in the treatment of natural outbreaks of swine respiratory disease (SRD) was evaluated at… (More)
Is this relevant?
2005
2005
The efficacy of tulathromycin in the treatment of bovine respiratory disease (BRD) due to Mycoplasma bovis was determined… (More)
Is this relevant?
2005
2005
The therapeutic efficacy and field safety of tulathromycin were evaluated in stocker calves with undifferentiated bovine… (More)
Is this relevant?
2005
2005
Four studies conducted at feedlots in Greeley and Wellington, Colorado; Nebraska; and Texas compared the efficacy of… (More)
Is this relevant?
2004
2004
The pharmacokinetics of the new triamilide antibiotic tulathromycin was investigated in two cattle studies. Following a single… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2004
2004
The absolute bioavailability and lung tissue distribution of the triamilide antimicrobial, tulathromycin, were investigated in… (More)
Is this relevant?